Bioinformatics analysis of potential common pathogenic mechanisms for systemic lupus erythematosus and acute

Yang Gao1, Yunxia Wang2, Muwei Li1

  • 1Department of Cardiology, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, China.

Lupus
|October 6, 2023
PubMed

Insights

Systemic lupus erythematosus (SLE) and acute myocardial infarction (AMI) share common molecular pathways. Identifying shared genes and pathways offers new insights into preventing and treating AMI in SLE patients.

Area of Science:

  • Molecular biology
  • Immunology
  • Cardiology

Background:

  • Patients with systemic lupus erythematosus (SLE) face an elevated risk of acute myocardial infarction (AMI).
  • The shared molecular mechanisms underlying this increased risk remain largely unelucidated.
  • This research investigates the common molecular underpinnings connecting SLE and AMI.

Purpose of the Study:

  • To identify common molecular mechanisms between SLE and AMI.
  • To uncover potential therapeutic targets for AMI in SLE patients.
  • To provide a foundation for future research into the pathogenesis of this complication.

Main Methods:

  • Comparative analysis of gene expression profiles from SLE (GSE50772) and AMI (GSE66360) datasets.
  • Identification of common differentially expressed genes (DEGs) between the two conditions.
  • Construction and analysis of protein-protein interaction (PPI) networks, regulatory networks, and identification of hub genes.

Main Results:

  • 70 common DEGs (7 downregulated, 63 upregulated) were identified between SLE and AMI.
  • Enrichment analysis revealed involvement in IL-17 signaling, TNF signaling, lipid metabolism, and atherosclerosis pathways.
  • 12 significant hub genes, including IL1B, TNF, and FOS, were identified as key players.

Conclusions:

  • This study elucidates shared pathogenic pathways between SLE and AMI.
  • The identified hub genes and pathways offer novel perspectives for understanding and treating AMI in SLE patients.
  • Findings may guide clinical strategies for the prevention and management of cardiovascular complications in SLE.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
19
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
101